Inhibiting CDK4/6 in pancreatic ductal adenocarcinoma via microRNA-21
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive malignancies, with a 5-year survival rate of 5–10 %. The high mortality rate is due to the asymptomatic progression of clinical features in metastatic stages of the disease, which renders standard therapeutic options futile. PDAC...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2023-06-01
|
| Series: | European Journal of Cell Biology |
| Assuntos: | |
| Acceso en liña: | http://www.sciencedirect.com/science/article/pii/S017193352300033X |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|